Today on DrugResearcher.com   New faces and a biotech baby at Pfizer seeking to reinvigorate ailing giant Horiba illuminates protein interactions Chilli hot on easing pain R&D news in brief Drugs moving into the clinic: 30

Related Industry News   GSK seeks WHO backing for cervical cancer vaccine Amgen indefinitely postpones Irish plant Polyclonal antibodies developed in transgenic chickens Genzyme gets slapped on the wrist by FDA

Breaking News on Drug Discovery
Daily  Friday 05 October 2007		Forward to a colleague

	Product Brochure Unique Process technology for drying very small quantities of API ProCepT's R&D Drying Technology for small quantities of API; SPRAY DRYING - NUTSCHE FILTER DRYING - AGITATED VACUUM DRYING - MICROWAVE DRYING. Fully instrumented and automated for Maximum of process knowledge with Minimum of API in a Minimum of time! Make use of the ProCepT lab... Click Here Access Full Stories New faces and a biotech baby at Pfizer seeking to reinvigorate ailing giant Pfizer has launched a new independent biotech centre and announced five new senior appointments, not least a new head of R&D, all geared towards reinvigorating the firm... Read Horiba illuminates protein interactions Horiba Jobin Yvon's protein interaction analyser, which can analyse up to 400 biomolecular interactions in 10 minutes, made its UK debut at the L.A.B. show on Tuesday. ... Read Chilli hot on easing pain An ingredient in chillies could form the basis of a new pain management formulation without creating numbness, researchers in the US have found... Read R&D news in brief DrugResearcher.com brings you a round up of the latest news in pharma research, including more pharma collaborations with charities and academia, and a 'virtual shopping centre' for gene regulation data... Read Drugs moving into the clinic: 30 The latest in a series of periodic roundups of drugs that have moved from preclinical research into clinical testing via the announcement of a Phase I trial or an application for a trial to industry regulators... Read
	All News Headlines for: October | September | August
	Application Notes Separation of polar compounds A Mini-tutorial to HILIC The ZIC®-HILIC column is the ideal choice for separation of polar and hydrophilic compounds. Amino acids, bases, peptides, carbohydrates, plant extracts and other polar compounds have good retention on the column from SeQuant - "The Number One in HILIC"... Click Here
	Related Industry News GSK seeks WHO backing for cervical cancer vaccine GlaxoSmithKline is seeking prequalification status from the World Health Organisation for its new cervical cancer vaccine, Cervarix, in a bid to speed up its availability to developing countries... Read Amgen indefinitely postpones Irish plant Amgen has announced the 'indefinite postponement' on plans for its $1bn (€0.71bn) manufacturing facility in Cork, Ireland, following further navel gazing by the company. ... Read Polyclonal antibodies developed in transgenic chickens The era of human polyclonal antibodies has dawned as efforts get underway to produce the next generation therapeutics in transgenic chickens... Read Genzyme gets slapped on the wrist by FDA The US Food and Drug Administration (FDA) has sent a letter to Genzyme to warn it about manufacturing issues at its biomanufacturing facility in Lyon, France... Read Inside India: special series Clinical trials in India: 'The wind is blowing' An industry veteran gives Outsourcing-Pharma.com an update on the state of the contract research organisation (CRO) industry in India. Read Sponsored Link DOSE IT - For easy dispensing of media and buffers Finally a programmable peristaltic pump with easy on-screen instructions and self-explanatory operation! If you are tired of complex pump operation, watch the DOSE IT online video or download the product information on the INTEGRA Biosciences website... Click Here Previous Headlines Bayer, Biocon discuss potential R&D and outsourcing deal German pharma firm Bayer is currently discussing with Indian company Biocon about a potential deal that would include the co-development of new biologics with an outsourcing element, according to Biocon... Read Investors jump into PDL stock in hope of imminent buyout Furious trading in shares of PDL BioPharma has taken place over the past couple of days as investors jumped in with both pockets open in the hope that a partner will soon be in the offing for the ailing firm... Read Eli Lilly: drug safety revolution 'within our grasp' The head of Eli Lilly has called for a reform of the US drug safety system, saying that an information revolution is 'within our grasp'... Read Big pharma enters stem cell domain to address safety, attrition Three of the world's biggest pharmaceutical companies have signed a landmark deal with the UK government that will see them use stem cell technology to road-test the safety of new compounds... Read 'Extreme PMT' gene not all the rage Researchers have, for the first time, unearthed a genetic variation that makes women more likely to suffer from the most extreme form of premenstrual tension or syndrome (PMT, PMS)... Read Product Information - brochures, Web centers Separation of polar compounds - Application Notes Product Innovation Alerts - Free of Charge Indicate your research interests and receive alerts on relevant products and market innovations Analysis and instrumentation Assays and screening Cell culture & Equipment Chromatography Compounds and consumables Contract services (outsourcing) Drug discovery Genomics / Proteomics Informatics & IT Lab equipment & consumables Liquid handling and automation Liquid handling and sample preparation Production technologies Separation and purification

	Free Newsletters for Pharmaceuticals Access now !Choose from over 20 industry e-newsletters Access Decision News Media e-newsletters for the food, beverage & nutrition industries, click here
	Forward to a colleague

	To continue to receive this newsletter in your inbox, please add newsletter@DrugResearcher.com to your address book
	Update preferences | Change your email address | Unsubscribe
	Contact us: Advertising | Recruitment | Privacy policy | Terms & conditions | Feedback
	© 2007 - Decision News Media S.A.S - All Rights Reserved Le Belem - 355, rue Vendemiaire - 34000 Montpellier - France http://www.decisionnewsmedia.com